Doubt the Market? 3 Stocks to Rideout Fear, Uncertainty and Doubt

Amidst market volatility, the article suggests investors consider blue-chip stocks with strong fundamentals and dividend yields. It highlights Philip Morris International (PM), trading at all-time highs with a focus on smokeless products and projected earnings growth exceeding 10%, Cardinal Health (CAH), which posted strong Q3 2025 earnings and raised full-year EPS guidance, and Alphabet Inc. (GOOGL), trading at a sub-20 P/E ratio with potential upside despite DOJ investigations and AI competition.

Analysis

The current market environment is characterized by significant volatility and conflicting signals, with solid technology earnings juxtaposed against pulled guidance from consumer-facing sectors like airlines and retailers. While economic data indicates resilience in consumer spending and the job market, public sentiment is deteriorating, and business surveys point to rising inflation expectations, further compounded by the uncertainty of erratic tariff policies. Despite the S&P 500 rallying over 15% from its April 8 low after a reciprocal tariff pause, it remains below its February all-time high, suggesting investor caution. In this climate, the article advocates for a "margin of safety" approach, focusing on blue-chip stocks for their potential to balance growth with security.

Philip Morris International (PM) is highlighted as a defensive play with growth prospects, offering a 3% dividend yield and a low 0.52 beta. The company's strategic pivot to smokeless products, such as ZYN nicotine pouches and IQOS, is gaining traction, with these products contributing over 40% to Q1 2025 revenue and ZYN shipments increasing by over 50% in the quarter. PM's stock reflects this momentum, reaching new all-time highs in 2025 with over 40% year-to-date gains, supported by expectations of earnings growth exceeding 10% over the next 12 months and a projected dividend payout ratio dropping to a manageable 68% in 2026, hinting at continued dividend increases.

Cardinal Health (CAH) demonstrates strength within the generally underperforming healthcare sector. Its stock has rallied over 25% in 2025, achieving new all-time highs, driven by robust earnings and a solid dividend history, featuring a dividend payout ratio under 35% and a 29-year track record of payment increases. The company's fiscal Q3 2025 earnings per share surpassed analyst estimates by 9% and grew over 13% year-over-year. Consequently, Cardinal Health raised its full-year 2025 EPS guidance to a range of $8.05 to $8.15, prompting analysts at Morgan Stanley and Robert Baird to boost price targets, indicating potential upside of 9% to 16% from current levels.

Alphabet Inc. (GOOGL) is presented as a mega-cap tech stock offering growth at an attractive valuation, with its price-to-earnings ratio falling below 20 for the first time since 2012 and a beta of 1.01 aligning its volatility closely with the S&P 500. Despite facing headwinds from DOJ investigations and competitive pressures highlighted by comments regarding AI's potential to replace traditional search, Alphabet reported strong top and bottom-line earnings on April 25 and initiated its first dividend payment last year. Analyst consensus points to a potential upside of over 15%, with an average price target of $199.

Key Decisions for Investors

• Investors should consider strategically allocating to blue-chip companies with robust fundamentals, proven dividend strength, and clear growth pathways as a measure to mitigate risk amid ongoing market volatility driven by mixed economic data and tariff uncertainties.
• Philip Morris International merits consideration for its defensive characteristics combined with significant expansion in the smokeless tobacco market, highlighted by its strong Q1 2025 performance in this segment and projected earnings growth above 10%, though its current all-time high valuation warrants careful entry point analysis.
• Cardinal Health presents a compelling case within the healthcare industry, supported by its consistent earnings outperformance, positive revision in full-year EPS guidance for 2025, and a reliable dividend growth profile, suggesting resilience.
• Alphabet Inc. may appeal to investors seeking growth at a reasonable price, given its historically low P/E ratio below 20 and significant analyst-projected upside, but potential investors must weigh these factors against ongoing regulatory scrutiny and emerging AI-driven competitive threats to its core search business.